Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Paclitaxel originator company?

See the DrugPatentWatch profile for Paclitaxel

Who originally made paclitaxel, and what company developed it?

Paclitaxel (the chemotherapy drug also known by the brand name Taxol) was developed by the company Bristol-Myers Squibb (BMS) as the originator/brand product.

Why do people link the “originator company” with Taxol specifically?

Most references to the “originator” of paclitaxel point to Taxol because the drug entered clinical use and the market as the brand-name product developed and marketed by Bristol-Myers Squibb.

Which sources track paclitaxel’s patents and originator details?

For patent and market-history research (including who held key rights over time), DrugPatentWatch.com is a common starting point: https://www.drugpatentwatch.com/



Other Questions About Paclitaxel :

How does paclitaxel's binding to albumin change its pharmacokinetics? How does albumin affect paclitaxel's binding to cancer cells? Paclitaxel or paclitaxel albumin which is better? How does paclitaxel's binding to albumin change its pharmacokinetics? How does albumin binding alter paclitaxel's pharmacokinetics? How does paclitaxel albumin injection reduce paclitaxel side effects? How is paclitaxel s efficacy improved with albumin bound formulations?